Form 4: UPEXI, INC. Director Thomas Charles Williams Acquires 25,000 Options
SEC Form 4 Filing
Director Thomas Charles Williams reports acquisition of 25,000 options to buy common stock in UPEXI, INC.
Summary
- On January 17, 2025, Thomas Charles Williams, a director of UPEXI, INC. (UPXI), acquired 25,000 options to buy common stock at a price of $3.46.
- The options are exercisable from April 17, 2025, and expire on January 17, 2035.
- Following the transaction, Williams directly owns 25,000 derivative securities.
Sentiment
Score: 6
Explanation: The sentiment is neutral. It's a standard regulatory filing detailing an insider transaction. The acquisition of options by a director could be interpreted slightly positively, suggesting confidence, but it's not definitively bullish.
Positives
- A director's acquisition of options can be seen as a positive signal, indicating confidence in the company's future performance.
Industry Context
This filing is a routine disclosure required by the SEC for corporate insiders, providing transparency to the market regarding their transactions in the company's securities.
Stakeholder Impact
- The transaction could have a minor positive impact on shareholder sentiment, as it signals confidence from a company director.
Key Dates
| Date | Description |
|---|---|
| 01/17/2025 | Date of transaction: Acquisition of options. |
| 04/17/2025 | Date options become exercisable. |
| 01/17/2035 | Expiration date of the options. |
| 04/24/2025 | Date of signature on the Form 4 filing. |
Keywords
Form 4, UPEXI, INC., UPXI, Thomas Charles Williams, Director, Options, Acquisition, Beneficial Ownership, Securities
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.